Ling Wei Selected Research

Biomarkers (Surrogate Marker)

1/2024	Exploration of potential shared gene signatures between periodontitis and multiple sclerosis.
1/2023	The correlation of retinal neurodegeneration and brain degeneration in patients with Alzheimer's disease using optical coherence tomography angiography and MRI.
1/2021	Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
1/2020	Noncoding RNAs in gastric cancer: implications for drug resistance.
12/2019	The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
10/2019	The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
10/2019	Saliva-derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non-small cell lung cancer.
7/2018	Application of multiplex methylated-specific PCR with capillary electrophoresis to explore prognostic value of TSGs hypermethylation for hepatocellular carcinoma.
2/2018	Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
9/2017	Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling Wei Research Topics

Disease

62	Neoplasms (Cancer) 01/2024 - 06/2004
46	Stroke (Strokes) 01/2024 - 04/2003
40	Ischemic Stroke 01/2023 - 07/2005
33	Infarction (Infarctions) 10/2021 - 05/2003
24	Ischemia 11/2022 - 05/2003
18	Brain Ischemia (Cerebral Ischemia) 01/2021 - 02/2003
17	Inflammation (Inflammations) 01/2024 - 07/2006
16	Hypoxia (Hypoxemia) 07/2022 - 05/2003
15	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 03/2011
13	Fibrosis (Cirrhosis) 10/2022 - 01/2012
13	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2004
9	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2012
8	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 01/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 03/2015
7	Infections 01/2024 - 08/2012
7	Brain Injuries (Brain Injury) 11/2022 - 02/2002
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 12/2006
6	Carcinogenesis 01/2024 - 11/2004
6	Cognitive Dysfunction 10/2023 - 09/2014
6	Liver Neoplasms (Liver Cancer) 01/2023 - 07/2005
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 08/2014
6	Lung Neoplasms (Lung Cancer) 01/2018 - 12/2006
5	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 12/2004
5	Hypothermia 02/2020 - 07/2012
5	Pain (Aches) 06/2018 - 07/2011
5	Necrosis 04/2018 - 02/2002
4	Anemia 01/2024 - 06/2008
4	Astigmatism 01/2020 - 06/2003
3	Myopia 05/2024 - 08/2023
3	Heart Failure 01/2024 - 11/2004
3	Myocardial Infarction 01/2024 - 04/2008
3	Weight Loss (Weight Reduction) 01/2024 - 12/2013
3	Cataract (Cataracts) 07/2022 - 01/2020
3	Chronic Renal Insufficiency 08/2021 - 06/2008
3	Hypertension (High Blood Pressure) 08/2021 - 04/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 12/2007
16	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2011
16	Bromodeoxyuridine (BrdU)IBA 10/2021 - 01/2007
11	Erythropoietin FDA Link 12/2017 - 04/2006
10	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 06/2012
10	CytokinesIBA 01/2021 - 06/2008
10	Caspase 3 (Caspase-3)IBA 01/2020 - 10/2004
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2005
9	Therapeutic UsesIBA 08/2020 - 01/2007
8	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 05/2007
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2023 - 02/2012
8	Messenger RNA (mRNA)IBA 01/2018 - 09/2002
8	CollagenIBA 08/2016 - 01/2012
7	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2006
6	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2010
6	Neurotensin Receptors (Neurotensin Receptor)IBA 02/2020 - 08/2014
5	Circular RNAIBA 01/2024 - 11/2019
5	AntibodiesIBA 09/2023 - 01/2018
5	SteroidsIBA 01/2023 - 06/2010
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2006
5	Neuroprotective AgentsIBA 01/2021 - 06/2010
5	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2020 - 02/2016
5	ABS-201IBA 01/2020 - 07/2012
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 11/2004
5	Interleukin-6 (Interleukin 6)IBA 10/2019 - 01/2012
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2006 - 09/2002
4	Indicators and Reagents (Reagents)IBA 01/2024 - 07/2010
4	RNA (Ribonucleic Acid)IBA 08/2023 - 02/2007
4	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 06/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 11/2004
4	3-n-butylphthalide (butylphthalide)IBA 10/2021 - 11/2010
4	Formaldehyde (Formol)FDA Link 12/2019 - 07/2011
4	Oxygen (Dioxygen)IBA 12/2016 - 10/2010
4	ErbB Receptors (EGF Receptor)IBA 09/2014 - 05/2008
3	HydrogelsIBA 01/2024 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2024 - 12/2007
3	Triglycerides (Triacylglycerol)IBA 12/2023 - 05/2020
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2023 - 01/2012
3	Cadherins (E-Cadherin)IBA 01/2023 - 11/2012
3	Monoclonal AntibodiesIBA 01/2023 - 05/2013
3	VaccinesIBA 03/2022 - 01/2020
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 10/2013
3	Uric Acid (Urate)IBA 08/2021 - 01/2015
3	Insulin (Novolin)FDA Link 08/2021 - 10/2020
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 02/2012
3	Cell-Free Nucleic AcidsIBA 10/2019 - 01/2018
3	Nuclear Proteins (Protein, Nuclear)IBA 07/2019 - 11/2008

Therapy/Procedure

60	Therapeutics 01/2024 - 07/2005
25	Transplantation 11/2022 - 06/2005
12	Drug Therapy (Chemotherapy) 01/2024 - 09/2002
11	Stem Cell Transplantation 01/2019 - 07/2005
8	Induced Hypothermia 02/2020 - 07/2012
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 08/2013
5	Lasers (Laser) 01/2021 - 05/2007
5	Ligation 01/2021 - 01/2012
5	Radiotherapy 08/2020 - 04/2005
4	Injections 01/2021 - 12/2014
4	Intranasal Administration 01/2021 - 01/2013
3	Transcranial Magnetic Stimulation 01/2024 - 03/2020
3	Immunotherapy 01/2023 - 01/2021
3	Treatment Delay 01/2021 - 01/2013
3	Heterologous Transplantation (Xenotransplantation) 01/2019 - 01/2017